SCHEMBL14810985

SCHEMBL14810985

CCOC(=O)C1CCN(C2CCN(C(=O)OCC)CC2)CC1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 3/20 0.76
MAPT P10636 2/20 0.60
GAA P10253 2/20 0.59
TDP1 Q9NUW8 2/20 0.58
TP53 P04637 1/20 0.58
ALDH1A1 P00352 2/20 0.57
KMT2A Q03164 2/20 0.54
HTT P42858 1/20 0.54
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
CHRM2 P08172 2/20 0.52
MAPK1 P28482 1/20 0.51
ALOX12 P18054 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
CHRM4 P08173 1/20 0.50
CHRM5 P08912 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14964843 0.94 CHRM1 (0.68) CHRM1MAPTGAATDP1TP53
SCHEMBL1720494 0.90 MAPT (0.72) CHRM1MAPTGAATDP1ALDH1A1
SCHEMBL14810278 0.89 CHRM1 (0.61) CHRM1MAPTGAATDP1TP53
SCHEMBL9408055 0.89 CHRM1 (0.61) CHRM1MAPTGAATDP1TP53
SCHEMBL14810258 0.88 CHRM1 (0.76) CHRM1GAATDP1TP53ALDH1A1
SCHEMBL12772860 0.86 CHRM1 (0.56) CHRM1MAPTALDH1A1KMT2AHTT
SCHEMBL31008743 0.85 ALDH1A1 (0.58) CHRM1MAPTALDH1A1KMT2ANPC1
SCHEMBL3273470 0.85 ALDH1A1 (0.62) CHRM1MAPTALDH1A1KMT2ANPC1
SCHEMBL25030784 0.85 SMN1; SMN2 (0.64) CHRM1MAPTALDH1A1KMT2AHTT
SCHEMBL28037969 0.84 CHRM1 (0.56) CHRM1MAPTTDP1TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9636335-B2 Heteroaryl compounds as 5-HT4 receptor ligands SUVEN LIFE SCIENCES LIMITED (IN) 2017-05-02 US disclosed
US-20150283125-A1 HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LTD (IN) 2015-10-08 US disclosed
US-9079894-B2 Heteroaryl compounds as 5-HT4 receptor ligands SUVEN LIFE SCIENCES LTD (IN) 2015-07-14 US disclosed
EP-2758394-B1 HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LTD (IN) 2015-02-18 EP disclosed
EP-2758394-A1 HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2014-07-30 EP disclosed
US-20140187581-A1 HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2014-07-03 US disclosed
WO-2013042135-A1 HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2013-03-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150283125-A1 HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS HTR4, HTR5A, HTR2C CHRM1 403/4885MAPT 2283/4885GAA 3230/4885
US-20140187581-A1 HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS HTR4, HTR5A, HTR2C CHRM1 403/4885MAPT 2283/4885GAA 3230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.